Jump to content

Disseminated coccidioidomycosis: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Consider adding the page number below in the number 1 reference. Should this References section be underneath the table?
m Added comma, deleted some spaces, moved table ahead of references
Line 29: Line 29:
== History of Treatment ==
== History of Treatment ==
{{copyedit section |date=December 2024}}
{{copyedit section |date=December 2024}}
In 1959, "Disseminated Coccidioidomycosis Treated with Amphotericin B" was published in the New York State Journal of Medicine, documenting perhaps one of the earliest uses of the drug, amphotericin B, for a patient who was admitted to the U.S. Public Health Service Hospital in Seattle, Washington. "Disseminated coccidioidomycosis had been lacking specific chemotherapeutic treatment until approximately three years ago when a polyene, antifungal antibiotic, amphotericin B, was tried. Since then there have been a number of reports on the beneficial clinical effect of the drug in patients with coccidioidomycosis. The reader is referred to Littman, Horowitz, and Swadey's article for a review of the salient features of coccidioidomycosis as well as the characteristics of amphotericin B. The purpose of this paper is to present another case of disseminated coccidioidomycosis treated with amphotericin B and followed for fourteen months." <ref>{{Cite journal |last=La Barbera, M.D. |first=Salvatore A. |date=October 1, 1959 |title=Disseminated Coccidioidomycosis Treated with Amphotericin B |journal=New York State Journal of Medicine |volume=59 |issue=19 |pages=3644}}</ref>
In 1959, "Disseminated Coccidioidomycosis Treated with Amphotericin B" was published in the New York State Journal of Medicine, documenting perhaps one of the earliest uses of the drug, amphotericin B, for a patient who was admitted to the U.S. Public Health Service Hospital in Seattle, Washington. "Disseminated coccidioidomycosis had been lacking specific chemotherapeutic treatment until approximately three years ago when a polyene, antifungal antibiotic, amphotericin B, was tried. Since then, there have been a number of reports on the beneficial clinical effect of the drug in patients with coccidioidomycosis. The reader is referred to Littman, Horowitz, and Swadey's article for a review of the salient features of coccidioidomycosis as well as the characteristics of amphotericin B. The purpose of this paper is to present another case of disseminated coccidioidomycosis treated with amphotericin B and followed for fourteen months." <ref>{{Cite journal |last=La Barbera, M.D. |first=Salvatore A. |date=October 1, 1959 |title=Disseminated Coccidioidomycosis Treated with Amphotericin B |journal=New York State Journal of Medicine |volume=59 |issue=19 |pages=3644}}</ref>

{{Mycoses}}


== See also ==
== See also ==
Line 37: Line 39:
== References <!-- Should this References section be underneath the table? -->==
== References <!-- Should this References section be underneath the table? -->==
{{reflist}}
{{reflist}}

{{Mycoses}}


[[Category:Mycosis-related cutaneous conditions]]
[[Category:Mycosis-related cutaneous conditions]]

Revision as of 21:31, 18 December 2024

Disseminated coccidioidomycosis
Other namesCoccidioidal granuloma
Characteristic skin granulomata on the forehead.
SpecialtyInfectious diseases

Disseminated coccidioidomycosis is a systemic infection with Coccidioides immitis, in which 15-20% of people develop skin lesions.[1]: 315 

History of Treatment

In 1959, "Disseminated Coccidioidomycosis Treated with Amphotericin B" was published in the New York State Journal of Medicine, documenting perhaps one of the earliest uses of the drug, amphotericin B, for a patient who was admitted to the U.S. Public Health Service Hospital in Seattle, Washington. "Disseminated coccidioidomycosis had been lacking specific chemotherapeutic treatment until approximately three years ago when a polyene, antifungal antibiotic, amphotericin B, was tried. Since then, there have been a number of reports on the beneficial clinical effect of the drug in patients with coccidioidomycosis. The reader is referred to Littman, Horowitz, and Swadey's article for a review of the salient features of coccidioidomycosis as well as the characteristics of amphotericin B. The purpose of this paper is to present another case of disseminated coccidioidomycosis treated with amphotericin B and followed for fourteen months." [2]

See also

References

  1. ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
  2. ^ La Barbera, M.D., Salvatore A. (October 1, 1959). "Disseminated Coccidioidomycosis Treated with Amphotericin B". New York State Journal of Medicine. 59 (19): 3644.